年轻气盛

Family Dollar issues mass nationwide recall on toothpaste, vitamins, pain relievers and more_我的网站

A |     　　继昨日大涨12%后，蘅东光今日（8月25日）再度长阳，截至收盘，其全天涨幅达6.87%，股价报收481.44元，在全市场位列第13位，同时盘中股价一度攀升至497.80元，逼近此前于今年6月录得的历史最高纪录。    Variety discount store Family Dollar recently initiated multiple recalls on products ranging from over-the-counter drugs to toothpaste sold at regional chains in nearly two dozen states.The company first issued an announcement Oct. 5, which was published Oct. 10 by the U.S. Food and Drug Administration, alerting Family Dollar shoppers of a voluntary recall on "over-the-counter drugs and medical devices" that had been "stored outside of labeled temperature requirements by Family Dollar and inadvertently shipped" to some of its stores from June 1 through Sept. 21, 2023.The wide range of recalled items includes cold medicine, pain relievers, mouthwash, moisturizer, vitamins and more. Affected products were sold in 23 states from June 1 through Oct. 4, 2023."To date, Family Dollar has not received any consumer complaints or reports of illness related to this voluntary recall," the company statement read. "This recall is being conducted out of an abundance of caution."Family Dollar did not immediately respond to ABC News' request for comment.Click here to see the full list of products included in the recall and SKU information."Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product," the company statement continued.Customers who purchased any of the recalled items are able to return them to the purchase location without a receipt for a refund.A full list of recalled items, as well as the states impacted, can be found on the FDA's website.Family Dollar experienced a similar issue earlier this spring when it voluntarily recalled seven Advil products that it said were also stored at the wrong temperature.。注：蘅东光近日持续走高（截至8月25日收盘）　　股价四日涨近四成，融资余额北证第二　　作为北交所股价和市值的“双冠王”，蘅东光的股价动向一直是市场关注焦点。

B | 本月以来，其股价持续攀升，截至今日收盘，月内累计涨幅已达112.18%，近4个交易日便贡献了近四成涨幅。目前，蘅东光股价报收481.44元，意味着仍需上涨约13.4%，方能突破今年6月创下的历史高点。

C | 　　从资金面来看，蘅东光近日融资余额有所回落。

D | 截至8月24日数据，其当前融资余额达3.27亿元，近2个交易日累计遭融资客减持0.39亿元，降幅接近一成比例。

E | 其中，蘅东光8月21日、24日融资净卖额分别达2216万元、1657万元。从全年行情上看，其融资余额仍处于年内高位水平。注：蘅东光近期融资余额变动情况（截至8月24日数据）　　从整个北交所个股层面来看，蘅东光目前的融资余额排名位居第二，仅次于戈碧迦（4.01亿元）。此外，另有11只北交所股的融资余额也在1亿元以上，分别为锦波生物、贝特瑞、连城数控、中科仪、曙光数创、长虹能源、并行科技、纳科诺尔、星图测控、艾融软件、民士达。注：北交所股融资余额排行榜（截至8月24日数据）　　北证百元标的扫描，两只股为年内上市　　受今年以来活跃行情提振，北交所股年内也表现活跃，截至今日收盘，当前共有6只百元股，较去年年末时的4只，增长了50%。按行业分布来看，上述6只个股所属板块较为分散，涵盖通信设备、医疗美容、自动化设备、IT服务、光学光电子、自动化设备板块。其中，鸿仕达、新睿电子为年内上市的新股。注：北交所高价股（截至8月25日收盘）　　具体个股来看，截至今日收盘，蘅东光以481.44元的股价高居北交所榜首，而位列次席的锦波生物则为上一代“北证股王”。回顾其巅峰时刻，锦波生物曾于2025年5月21日一度录得577.50元的历史最高收盘价，在当时全市场个股中位列第三，仅次于贵州茅台（1580.97元）与寒武纪（666.49元）。

F | 　　从量能维度来看，北交所本月日均成交额超2亿元的个股共18只。头部梯队中，蘅东光以6.75亿元领先，戈碧迦、杰理科技分别以6.28亿元、4.45亿元位列其后。第二梯队则聚集了中科仪、惠丰钻石、信胜科技、森合高科、双英集团、鸿仕达、长鹰硬科、科力股份等活跃标的。注：北交所个股月内日均成交额排行榜（截至8月25日收盘）（文章来源：财联社）。

G |

Current article:http://www.zhanggengsenchaiweikeng.cfd/news/20260826_2702.xls

Published on:03:13:21